English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech Healthcare & Pharm
World-first Hip Fracture Registry Toolbox striving to improve care for the 1 million+ who fracture a hip in Asia Pacific each year
Jun 15, 2021 17:30 HKT
World-first Hip Fracture Registry Toolbox striving to improve care for the 1 million+ who fracture a hip in Asia Pacific each year
Jun 15, 2021 17:00 HKT
Cofttek Announces Mass-Production and Supply of Urolithin A & B
Jun 15, 2021 11:00 HKT
医思健康收购宠物相关业务 发挥客户业务协同性 整合及企业化宠物市场
Jun 15, 2021 08:02 HKT
醫思健康收購寵物相關業務 發揮客戶業務協同性 整合及企業化寵物市場
Jun 15, 2021 08:01 HKT
EC Healthcare Acquires Pet Industry Business, Allowing Clientele and Business Synergies, To Consolidate and Corporatize Pet Industry
Jun 15, 2021 08:00 HKT
医思健康与康哲药业签署战略合作备忘录 发挥医美上下游协同效应 共同促进行业之医学产品及人才发展
Jun 11, 2021 08:17 HKT
醫思健康與康哲藥業簽署戰略合作備忘錄 發揮醫美上下游協同效應 共同促進行業之醫學產品及人才發展
Jun 11, 2021 08:16 HKT
Strategic Collaboration Memorandum between EC Healthcare and China Medical System Utilizes the Synergy of Upstream and Downstream of the Aesthetic Medical Industry, Promotes the Development of Medical Products and Talents
Jun 11, 2021 08:15 HKT
叮当快药完成新一轮2.2亿美元融资
Jun 08, 2021 09:35 HKT
叮當健康完成新一輪2.2億美元融資
Jun 08, 2021 09:34 HKT
Dingdang Health raises US$220 million in new financing round
Jun 08, 2021 09:33 HKT
正处CAR-T细胞疗法黄金赛道 科济药业今日招股
Jun 07, 2021 11:57 HKT
正處CAR-T細胞療法黃金賽道 科濟藥業今日招股
Jun 07, 2021 11:56 HKT
Avance Clinical's USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities
Jun 04, 2021 08:00 HKT
集众多优势于一身 时代天使弯道超车未来可期
Jun 03, 2021 16:21 HKT
集眾多優勢於一身 時代天使彎道超車未來可期
Jun 03, 2021 16:20 HKT
Avantor®收购RIM Bio,将生物制品生产业务扩展至中国
Jun 02, 2021 08:54 HKT
Avantor Acquires RIM Bio; Expands Bioproduction Footprint into China
Jun 02, 2021 08:28 HKT
아반토, RIM Bio 인수로 중국에서의 바이오 생산 확장
Jun 02, 2021 08:21 HKT
Next >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: